Van Der Laan, Luc J.

Publishing since 1997 (Senior)

Has published 30 publications in 14 years

Number of publications published per year by Van Der Laan, Luc J.. (Source : PubMed)

Distribution of publications types for Van Der Laan, Luc J.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Pan Q, Metselaar HJ, de Ruiter P, Kwekkeboom J, Tilanus HW, Janssen HL, van der Laan LJ. Calcineurin inhibitor tacrolimus does not interfere with the suppression of hepatitis C virus infection by interferon-alpha.  Liver Transpl.  2010;16;4  
•  Sewgobind VD, van der Laan LJ, Kho MM, Kraaijeveld R, Korevaar SS, van Dam T, Ijzermans JN, Weimar W, Baan CC. Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease.  Transplantation  2010;89;6  
•  Bosma BM, Metselaar HJ, Gerrits JH, van Besouw NM, Mancham S, Groothuismink ZM, Boor PP, van der Laan LJ, Tilanus HW, Kuipers EJ, Kwekkeboom J. Migration of allosensitizing donor myeloid dendritic cells into recipients after liver transplantation.  Liver Transpl.  2010;16;1  
•  Boonstra A, van der Laan LJ, Vanwolleghem T, Janssen HL. Experimental models for hepatitis C viral infection.  Hepatology  2009;50;5  
•  Demirkiran A, Sewgobind VD, van der Weijde J, Kok A, Baan CC, Kwekkeboom J, Tilanus HW, Metselaar HJ, van der Laan LJ. Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells.  Transplantation  2009;87;7  
•  Henry SD, van der Wegen P, Metselaar HJ, Scholte BJ, Tilanus HW, van der Laan LJ. Hydroxyethyl starch-based preservation solutions enhance gene therapy vector delivery under hypothermic conditions.  Liver Transpl.  2008;14;12  
•  Bosma BM, Metselaar HJ, Nagtzaam NM, de Haan R, Mancham S, van der Laan LJ, Kuipers EJ, Kwekkeboom J. Dexamethasone transforms lipopolysaccharide-stimulated human blood myeloid dendritic cells into myeloid dendritic cells that prime interleukin-10 production in T cells.  Immunology  2008;125;1  
•  Sewgobind VD, van der Laan LJ, Klepper M, Ijzermans JN, Tilanus HW, Weimar W, Baan CC. Functional analysis of CD4+ CD25bright T cells in kidney transplant patients: improving suppression of donor-directed responses after transplantation.  Clin Transplant  2008;22;5  
•  Demirkiran A, Hendrikx TK, Baan CC, van der Laan LJ. Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting?  Transplantation  2008;85;6  
•  Watashi K, Metselaar HJ, van der Laan LJ. Interfering with interferon: re-igniting the debate on calcineurin inhibitor choice and antiviral therapy for hepatitis C virus recurrence.  Liver Transpl.  2008;14;3  

[ See timeline ] [ See all publications ]